Welcome readers,
This week's deals come from Belgium, Germany, Ireland, the Netherlands and the UK. Some highlights: Larry Ellison commits £890 million to Oxford, AB Enzymes takes Darmstadt headquarters and Kadans opens Utrecht Science Park. We also examine how Europe’s second-hand lab equipment market offers landlords a practical way to recover value and reduce fit-out risk.
🔒 Paying subscribers get 12 deals • Everyone else can explore 3 of them → Get full access by subscribing here.
— Stephen Ryan (connect with me on LinkedIn)
🔍 Do you need deeper insights into life sciences real estate?
In addition to our regular updates, we offer bespoke research and strategic analysis for investors and developers in the life sciences sector. Whether you’re evaluating an acquisition, tracking market trends, or need a custom report, our team can help you make informed decisions.
Get in touch to discuss how we can support your next project.
Featured article of the week
Beyond sunk costs: how Europe’s second-hand lab market protects landlords
Europe’s second-hand lab equipment market offers landlords a practical way to recover value and reduce fit-out risk.
Deals
BELGIUM NIVELLES
Property developer BVI.EU has delivered a 1,400 sq m facility for Lepivits at Nivelles North Green Business Park, comprising 200 sq m of food-grade cleanroom space, an R&D laboratory and office accommodation. The nutraceutical company is investing €4 million in the project, which will be operational from April 2026. The development was delivered by BVI.EU's Life Sciences Business Unit, established to serve Belgium's health and biotech sectors.
GERMANY DARMSTADT
ALÌTUS Capital Partners has appointed LIST BiB as general contractor for modernisation of the 10,000 sq m KALA building at Central Campus Darmstadt. AB Enzymes has signed a 20-year green lease for over 7,300 sq m to establish its global headquarters, with fit-out scheduled for completion in the third quarter of 2026. The comprehensive revitalisation will create new office and laboratory spaces, with full project completion scheduled for early 2027. A further 1,800 sq m of office and laboratory space will be available for letting, with marketing commencing at the end of 2025.
Would you like instant access to 1,200+ deals like these? Our data tool lets you filter, sort and search European life sciences transactions spanning 24 countries—whether you're tracking a single city or spotting market patterns others miss.
IRELAND MULLINGAR
G&F Precision Molding, a US-based manufacturer for the medical device and life sciences sectors, launched its Irish operations in October 2025 with a new engineering and sales facility in Mullingar, County Westmeath. The site offers R&D, engineering, and sales functions for pharma, medical technology, and digital health clients. Tracey Brothers delivered the 4,727 sq m building with support from Ireland's Industrial Development Authority.
👇 As a free member, you get access to three deals for free.
Upgrade now to access the full list.
